Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 1
2005 1
2006 3
2007 1
2008 1
2009 1
2010 2
2011 2
2012 5
2013 7
2014 4
2015 1
2016 5
2018 2
2019 1
2020 4
2021 5
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Empirical Antitubercular Treatment for Lymphadenopathy: Are We Missing Lymphoma?
Mahajan A, Bakhshi S, Singh M, Seth R, Verma N, Jain S, Radhakrishnan V, Mandal P, Arora RS, Dinand V, Kalra M, Kapoor G, Sajid M, Kumar R, Mallick S, Taluja A, Chandra J. Mahajan A, et al. Among authors: dinand v. Indian J Pediatr. 2023 Aug;90(8):761-765. doi: 10.1007/s12098-022-04180-6. Epub 2022 Jun 23. Indian J Pediatr. 2023. PMID: 35737182
Hodgkin Lymphoma in Children Under 5 Years: Do They Behave Differently?
Mahajan A, Bakhshi S, Seth R, Verma N, Mandal P, Singh M, Jain S, Radhakrishnan V, Kanvinde S, Arora RS, Dinand V, Kalra M, Taluja A, Mallick S, Kumar R, Chandra J. Mahajan A, et al. Among authors: dinand v. J Pediatr Hematol Oncol. 2022 May 1;44(4):186-190. doi: 10.1097/MPH.0000000000002423. Epub 2022 Mar 16. J Pediatr Hematol Oncol. 2022. PMID: 35293880
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experience.
Mahajan A, Singh M, Bakhshi S, Jain S, Radhakrishnan V, Verma N, Seth R, Arora RS, Dinand V, Kalra M, Mandal P, Kapoor G, Sajid M, Thulkar S, Arora A, Taluja A, Chandra J. Mahajan A, et al. Among authors: dinand v. Pediatr Blood Cancer. 2021 Oct;68(10):e29219. doi: 10.1002/pbc.29219. Epub 2021 Jul 22. Pediatr Blood Cancer. 2021. PMID: 34291860 Clinical Trial.
Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01.
Jain S, Bakhshi S, Seth R, Verma N, Singh M, Mahajan A, Radhakrishnan V, Mandal P, Arora R, Dinand V, Kalra M, Sharma A, Taluja A, Thulkar S, Biswas A, Chandra J. Jain S, et al. Among authors: dinand v. Leuk Lymphoma. 2022 May;63(5):1111-1118. doi: 10.1080/10428194.2021.2012659. Epub 2021 Dec 9. Leuk Lymphoma. 2022. PMID: 34881686
Response assessment by positron emission tomography-computed tomography as compared with contrast-enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low- and middle-income countries.
Kalra M, Bakhshi S, Singh M, Seth R, Verma N, Jain S, Radhakrishnan V, Mandal P, Mahajan A, Arora RS, Dinand V, Kapoor G, Sajid M, Kumar R, Taluja A, Mallick S, Chandra J. Kalra M, et al. Among authors: dinand v. Pediatr Blood Cancer. 2023 Feb;70(2):e30091. doi: 10.1002/pbc.30091. Epub 2022 Nov 21. Pediatr Blood Cancer. 2023. PMID: 36411263
Antioxidant levels at diagnosis in childhood acute lymphoblastic leukemia.
Radhakrishnan N, Dinand V, Rao S, Gupta P, Toteja GS, Kalra M, Yadav SP, Sachdeva A. Radhakrishnan N, et al. Among authors: dinand v. Indian J Pediatr. 2013 Apr;80(4):292-6. doi: 10.1007/s12098-012-0892-8. Epub 2012 Nov 28. Indian J Pediatr. 2013. PMID: 23188708
40 results